Press Releases

The 3rd Alzheimer's-Focused #C4CT Concussion Summit Convenes Today at the United Nations

Hosted by Amarantus and Brewer Sports

NEW YORK, July 31, 2014 (GLOBE NEWSWIRE) -- Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to cell cycle dysregulation, endoplasmic reticulum stress, neurodegeneration and apoptosis, will be hosting the 3rd Alzheimer's-Focused #C4CT Summit powered by MDM Worldwide at the United Nations today.

The Summit will focus on the current state of concussions and the potential link between traumatic brain injury (TBI) and neurodegenerative diseases like Alzheimer's. A diverse working group of clinicians, medical researchers, policy makers, international diplomats, athletes, celebrities, and philanthropic organizations will be assembled to raise awareness, advance clinical research, and develop public policy in order to address this major unmet medical need and public health issue.

The Summit will be broadcast live here. There will also be live Tweets from @BrewerSports, @Amarantusbio, and @MDMWorldwide throughout the day. All can join the conversation on Twitter by using the hashtag #C4CT.

#C4CT Concussion Awareness Summit Agenda

Thursday, July 31, 2014 // United Nations // 9:00am - 6:00pm // *All times and panelists/presenters subject to change

9:00am – 9:20am: Opening Keynote

  • The Honorable Chaka Fattah (D-PA), Member of Congress

9:30am - 10:00am: Welcome

  • H.E. Ambassador Jack Brewer, CEO of The Brewer Group, Inc.
  • Gerald Commissiong, President & CEO of Amarantus BioScience
  • Janet Carbary, CFO of One Mind
  • H.E. Ambassador Ali'ioaiga Feturi Elisaia, Permanent Mission of the Independent State of Samoa to the United Nations

10:00am - 10:40am: Brain Trauma Leading to Alzheimer's Disease and Chronic Traumatic Encephalopathy: What We Know and What We Need to Know

  • Robert Stern, Ph.D., Professor of Neurology, Neurosurgery, and Anatomy and Neurobiology, Clinical Core Director of BU Alzheimer's Disease Center, Boston University School of Medicine

10:50am - 11:50am: The Current State of Sports Concussion Panel

Moderator: Robert Cantu, M.A., M.D., F.A.C.S., F.A.A.N.S., F.I.C.S., F.A.C.S.M., Clinical Professor of Neurology and Neurosurgery, Boston University School of Medicine; Medical Director of National Center for Catastrophic Sport Injury Research and Sports Legacy Institute (SLI)

  • Charles Bernick, M.D., Associate Director, Cleveland Clinic Lou Ruvo Center for Brain Health
  • Allen Brown, M.D., Consultant, Chair, Division of Brain Rehabilitation, Department of Physical Medicine and Rehabilitation; Project Director, Traumatic Brain Injury Model Systems Center, Mayo Clinic in Rochester, MN
  • Anthony Choo, Ph.D., Senior Scientist at PsychoGenics
  • Stefan M. Duma, Ph.D., Harry C. Wyatt Professor and Department Head, Virginia Tech - Wake Forest University School of Biomedical Engineering and Sciences
  • Andrew Maas, M.D., Ph.D., Professor and Chairman, Department of Neurosurgery, Antwerp University Hospital and University of Antwerp
  • Chris Nowinski, Co-Founder & Executive Director of Sports Legacy Institute; Co-Director for the Center for the Study of Traumatic Encephalopathy at Boston University School of Medicine; Former WWE Wrestler
  • Adam Simon, President & CEO of Cerora

12:00pm - 1:00pm: Networking Lunch

1:10pm - 2:15pm: New Insights from Recent Alzheimer's Research: Implications for TBI and CTE

Moderator: Howard Fillit, M.D., Executive Director and Chief Science Officer, Alzheimer's Drug Discovery Foundation

  • Donna Cross, Ph.D., Associate Professor of Radiology; Director, WaNPRC PET Imaging Center; Co-Director CHDD Small Animal Imaging Core, University of Washington, Department of Radiology
  • Robert Stern, Ph.D., Professor of Neurology, Neurosurgery, and Anatomy and Neurobiology, Clinical Core Director of BU Alzheimer's Disease Center, Boston University School of Medicine
  • Bruce Lamb, Ph.D., Staff Scientist Department of Neurosciences, The Cleveland Clinic Foundation
  • Bobby Heagerty, MA, Director of Community Affairs & Education at OHSU Brain Institute

2:20pm - 3:00pm: Emerging Theories in Alzheimer's Disease

  • Thomas Arendt, M.D., DSc., Managing Director of the Paul Flechsig Institute of Brain Research, Leipzig University and Director of the Alzheimer Centre Leipzig
  • Dr. Louis Kirby, Board of Advisors, Amarantus BioScience

3:00pm - 3:45pm: Family Offices Panel

Moderator: J. Michael Moffat, Chief Executive Officer and Head of Family Office Relations, Cavendish Global; Founder and Chief Executive Officer of Black Ash Holdings; Director of USNY Bank; Board of Directors and Board of Trustees of The Scriven Foundation, The Farmers' Museum, and Bassett Healthcare Network

  • Walter Schmidt, Ph.D., Chief Executive Officer, Affiris AG
  • Frank Mattner, Ph.D., Chief Scientific Officer, Affiris AG
  • Rick Fort, Ph.D., President and CEO, Family Office Investor, CereScan
  • S. Gregory Hipskind, M.D., Ph.D., Chief Medical Advisor, CereScan

3:50pm - 4:40pm: Public Policies Panel

Moderator: Andrea Kremer, Chief Correspondent for Player Health and Safety at the NFL Network

  • Janet Carbary, CFO of One Mind
  • Gerald Commissiong, President & CEO of Amarantus BioScience
  • Susan Connors, President & CEO of Brain Injury Association of America
  • Nicole Fisher, M.P.P., Ph.D. Student, HHR Strategies, Inc, Forbes Contributor
  • The Honorable James C. Greenwood, President & CEO of the Biotechnology Industry Organization (BIO)
  • Scott Liebman, Partner, Loeb & Loeb LLP
  • Jeff Last, Associate Director for Federal Affairs, Public Policy Office of the Alzheimer's Association

4:45pm - 5:10pm: Ben Utecht Video Presentation

5:10pm – 5:25pm: Andrea Kremer Exclusive Interview with Sidney Rice

5:30pm - 6:15pm: Current and Former Professional Athletes' Personal Stories

Moderator: Andrew Brandt, NFL Business Analyst, ESPN

  • Alecko Eskandarian, Former MLS Player, Assistant Coach, New York Cosmos
  • EJ Henderson, NFL Pro Bowler, Former NFL Linebacker
  • Qiana Martin, International Athlete/Global Soccer Ambassador
  • Clinton Portis, 2X NFL Pro Bowler, Former NFL Running Back
  • Darrell Reid, NFL Super Bowl Champion, Former NFL Linebacker
  • Sidney Rice, NFL Pro Bowler, Super Bowl Champion
  • Ben Utecht, NFL Super Bowl Champion, Recording Artist, Motivational Speaker, and National Concussion and Brain Disease Advocate, Recipient of 2014 PLINA Award (Public Leadership In Neurology Award)


The Coalition for Concussion Treatment (#C4CT) serves as a platform to spread awareness about concussions and the severe effects of Traumatic Brain Injury (TBI). Through a global campaign uniting people who are passionate about the cause, #C4CT fosters the critical discussions and partnerships needed to enhance research, treatment efforts and prevention. The overall goal of the coalition is to continue building awareness of key scientific and medical advances in an ongoing effort to identify and develop new TBI treatment opportunities.


Thursday, July 31, 2014 
United Nations, New York City 
Doors open at 8:30 am // Summit starts at 9:00 am 
Presented By: Amarantus Bioscience Holdings and Brewer Sports International 
Powered By: MDM Worldwide 
Topics Include: The Current State of Sports Concussions, TBI and the Potential Link to Alzheimer's disease, Alzheimer's Research and Potential Treatments, Funding and Public Policy, Current and Former Professional Athletes' Personal Stories

More Info on:

Share your support for #C4CT on Twitter!

About #C4CT

The Coalition for Concussion Treatment (#C4CT) was founded in 2012 by former NFL player Jack Brewer, CEO of Brewer Sports International and Gerald Commissiong, President and CEO at Amarantus BioScience Holdings, Inc. with the goal of bringing together those who are directly affected by TBI-induced neurodegenerative diseases with world class researchers, scientists, and industry leaders who are actively working towards identifying and developing innovative TBI treatment opportunities. #C4CT serves as a platform to spread awareness about concussions and the severe effects of Traumatic Brain Injury (TBI). #C4CT fosters the critical discussions and partnerships needed to enhance research, treatment efforts, and prevention through a global campaign uniting people who are passionate about the cause. 

About Amarantus BioScience Holdings, Inc.

Amarantus BioScience Holdings (AMBS) is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. AMBS has licensed Eltoprazine ("Eltoprazine"), a phase 2b ready small molecule indicated for Parkinson's Levodopa induced dyskinesia and Adult ADHD. AMBS has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test®") for Alzheimer's disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. AMBS also owns intellectual property for the diagnosis of Parkinson's disease ("NuroPro") and the discovery of neurotrophic factors ("PhenoGuard"). Amarantus operations are located at Janssen Labs @QB3 in San Francisco, CA. For further information please visit, or connect with the Company on Facebook, LinkedIn, Twitter and Google+.

About Brewer Sports International

Founded by international entrepreneur Jack Brewer, five-year National Football League (NFL) veteran and former three-team captain, Brewer Sports International (BSI) is a multi-faceted global sports advisory firm within The Brewer Group Companies with a focus on the business of sport and wellness for professional athletes, sports agencies, public and private corporations and various partners including international organizations, governments and NGOs. Based in Minneapolis with offices spanning the globe, BSI offers a unique financial services platform to professional athletes and sports agencies, as well as high-net-worth individuals and businesses related to sports. BSI takes pride in enabling its clients to capitalize on the endless opportunities presented through sport. For more information, please visit or follow them on Facebook, Twitter and LinkedIn.

About MDM Worldwide

MDM Worldwide Solutions, Inc. is a digital communications agency that develops and manages online engagement strategies to connect companies with their stakeholders. MDM specializes in working with clients in the technology, healthcare and life sciences spaces. MDM's vast industry knowledge, proprietary methodology, proven track record and experienced leadership team enables them to create and customize targeted digital marketing campaigns to fulfill all of their clients' objectives. For more information, please visit or find them on FacebookTwitterGoogle+ and LinkedIn.

Amarantus Bioscience Holdings, Inc.:
Aimee Boutcher, Director of Investor Relations
408.737.2734 x 101

Brewer Sports International:
Kristi Hofacker, Director of Interactive Marketing & Media
The Brewer Group, Inc.